U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
5982159821Study of Abdominal Aortic Stent Grafts in the Treatment of Infrarenal Abdominal Aortic AneurysmsActive, not recruitingNo Results AvailableAbdominal Aortic Aneurysmhttps://ClinicalTrials.gov/show/NCT01783184
5982259822Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed by SurgeryRecruitingNo Results AvailablePancreatic Adenocarcinoma|Recurrent Pancreatic Carcinoma|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer|Unresectable Pancreatic CancerDrug: Akt Inhibitor MK2206|Drug: Dinaciclib|Other: Laboratory Biomarker Analysis|Other: Pharmacological Studyhttps://ClinicalTrials.gov/show/NCT01783171
5982359823Chromoendoscopy to Detect Early Synchronous Second Primary Esophageal CarcinomaCompletedNo Results AvailableSquamous Cell Carcinomas of the Head and NeckProcedure: Esophagoscopy and chromoendoscopyhttps://ClinicalTrials.gov/show/NCT01783158
5982459824Shared Care Follow-up After Chemotherapy for Testicular CancerRecruitingNo Results AvailableTesticular Cancerhttps://ClinicalTrials.gov/show/NCT01783145
5982559825Optimization of Inhaled Corticosteroid Treatment in Adult Patients With Asthma Guided by Exhaled NO Measurement at HomeRecruitingNo Results AvailableAsthmaDevice: NIOX MINOhttps://ClinicalTrials.gov/show/NCT01783132
5982659826Effect of Aloe Vera in the Inflammation of Patients With Mild Ulcerative ColitisRecruitingNo Results AvailableUlcerative ColitisDietary Supplement: Aloe Barbadensis Miller|Dietary Supplement: placebo waterhttps://ClinicalTrials.gov/show/NCT01783119
5982759827Antibiotics and Hydroxychloroquine in Crohn'sRecruitingNo Results AvailableCrohn's DiseaseDrug: Ciprofloxacin|Drug: Doxycycline|Drug: Hydroxychloroquine|Drug: Budesonidehttps://ClinicalTrials.gov/show/NCT01783106
5982859828Tricuspid Regurgitant Jet Velocity as an Independent Marker for Mortality in Sickle Cell AnemiaCompletedNo Results AvailableSickle Cell Anemia|Pulmonary HypertensionOther: Data Collectionhttps://ClinicalTrials.gov/show/NCT01783093
5982959829Behavioral Activation (BA) for Medication-responsive Chronically Depressed Patients With Impaired Social FunctioningCompletedNo Results AvailableMedication-responsive Chronic Depression (CD).Behavioral: Behavioral Activation for return to workhttps://ClinicalTrials.gov/show/NCT01783080
5983059830Zinc and Iron Bioavailability From Biofortified Pearl MilletCompletedNo Results AvailableNutritional DeficiencyOther: Pearl millet|Other: Biofortified pearl millethttps://ClinicalTrials.gov/show/NCT01783067
5983159831Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the PancreasRecruitingNo Results AvailableAdenocarcinoma PancreasProcedure: Surgery|Genetic: Genetic Expression|Drug: Chemotherapyhttps://ClinicalTrials.gov/show/NCT01783054
5983259832Effect of Early L-Carnitine Supplementation on Neurodevelopmental Outcomes in Very Preterm InfantsRecruitingNo Results AvailablePrematurity|Neurodevelopmental Disorder|Carnitine DeficiencyDrug: L-carnitine|Drug: 5% Dextrosehttps://ClinicalTrials.gov/show/NCT01783041
5983359833Home-Based Asthma Support and Education for AdultsCompletedNo Results AvailableAsthmaBehavioral: Community Health Worker supporthttps://ClinicalTrials.gov/show/NCT01783028
5983459834Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus MethotrexateTerminatedNo Results AvailableRheumatoid ArthritisDrug: Etanercept|Drug: Etnaercept|Drug: Placebo|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01783015
598355983511C Methionine PET for the Detection of Hyperfunctional Parathyroid TissuesRecruitingNo Results AvailablePrimary HyperparathyroidismRadiation: 11C-Methionine PET/CT scanning|Radiation: 18F-FDG PET/CT scanning|Radiation: SPECT-CT scanninghttps://ClinicalTrials.gov/show/NCT01783002
5983659836Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)RecruitingNo Results AvailableGeographic AtrophyDrug: ORACEA®|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01782989
5983759837Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)WithdrawnNo Results AvailableGlioblastomaDrug: Cilengitide|Drug: Bevacizumab|Behavioral: Questionnairehttps://ClinicalTrials.gov/show/NCT01782976
5983859838Lenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM)Active, not recruitingNo Results AvailableMultiple MyelomaDrug: Lenalidomide|Drug: Bortezomib|Drug: Dexamethasonehttps://ClinicalTrials.gov/show/NCT01782963
5983959839Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment OutcomesRecruitingNo Results AvailableAIDS With TuberculosisDrug: Rifampicin, Isoniazid, Ethambutol, Pyrazinamidehttps://ClinicalTrials.gov/show/NCT01782950
5984059840An Open-label, Non-controlled Study of KHK4827 in Subjects With PsoriasisCompletedNo Results AvailablePsoriasisDrug: KHK4827https://ClinicalTrials.gov/show/NCT01782937
5984159841A Phase 3 Clinical Study of KHK4827CompletedNo Results AvailablePsoriasisDrug: KHK4827https://ClinicalTrials.gov/show/NCT01782924
5984259842Effect of Resveratrol on Metabolic Parameters and Oocyte Quality in PCOS PatientsNot yet recruitingNo Results AvailableAndrogen Profile|Inflammatory Markers|IVF OutcomeDietary Supplement: Resveratrol|Dietary Supplement: Placebo pillshttps://ClinicalTrials.gov/show/NCT01782911
5984359843The Effect of Intraoperative Esmolol to Improve Postoperative Quality of Recovery and Pain After Ambulatory SurgeryCompletedNo Results AvailablePainDrug: Esmolol administered at a rate of 0.5 mg/kg followed by an infusion of 5-15 mcg/kg/min|Drug: Placebo Comparator: .9 normal salinehttps://ClinicalTrials.gov/show/NCT01782898
5984459844In Vivo and in Vitro Evaluation of PRP TherapyRecruitingNo Results AvailableKnee OsteoarthritisProcedure: Intra-articular injection of PRPhttps://ClinicalTrials.gov/show/NCT01782885
5984559845Analgesia After Total Shoulder ArthroplastyCompletedNo Results AvailableTotal Shoulder ArthroplastyProcedure: Interscalene Block (ISB) - 0.375% Ropivacaine + additives|Procedure: Interscalene Block (ISB) - 0.2% Ropivacaine + additives|Procedure: Interscalene Block (ISB) - 0.1% Ropivacaine + additives|Procedure: Interscalene Block (ISB) - Systemic Controlhttps://ClinicalTrials.gov/show/NCT01782872
5984659846Effect of Steroids on Thrombosis (Blood Clot Formation) and Inflammation in Patients Undergoing Hip SurgeryRecruitingNo Results AvailableTotal Hip ReplacementDrug: Prednisone|Drug: Hydrocortisone|Drug: Placebo (for Prednisone)https://ClinicalTrials.gov/show/NCT01782859
5984759847Trama-Code (Two Analgesics-comparative Study)RecruitingNo Results AvailablePainDrug: Ixprim®|Drug: Dafalgan-Codeine®https://ClinicalTrials.gov/show/NCT01782846
5984859848Pletaal SR Post Marketing Observational StudyNot yet recruitingNo Results AvailableTreatment of Ischemic Symptom and Prevention of Recurrence of Cerebral InfarctionDrug: Pletaalhttps://ClinicalTrials.gov/show/NCT01782833
5984959849Influence of a Single Dose Dexamethasone on the Time Course of Neuromuscular Blockade of RocuroniumCompletedNo Results AvailableNeuromuscular Block, Dexamethasone|Neuromuscular Block, Recoveryhttps://ClinicalTrials.gov/show/NCT01782820
5985059850Ovarian Function After Hysterectomy With or Without Fimbriectomy or SalpingectomyRecruitingNo Results AvailableOvarian Function InsufficiencyProcedure: Salpingectomy or Fimbriectomyhttps://ClinicalTrials.gov/show/NCT01782807

* Görseller ve İçerik tekif hakkına sahip olabilir